Celularity Inc
(CELU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 738 | 227 | 13,966 | 37,240 | 54,311 |
| Receivables | 13,557 | 12,118 | 6,966 | 5,233 | 6,550 |
| Inventories | 5,409 | 5,753 | 5,308 | 9,549 | 3,850 |
| Other current assets | 0 | 0 | 0 | 0 | 873 |
| TOTAL | $20,561 | $19,793 | $33,502 | $59,100 | $72,160 |
| Non-Current Assets | |||||
| PPE Net | 61,600 | 67,828 | 75,655 | 90,625 | 90,077 |
| Intangibles | 16,595 | 18,348 | 240,688 | 246,491 | 248,683 |
| Other Non-Current Assets | 33,926 | 37,920 | 51,221 | 17,912 | 20,088 |
| TOTAL | $112,121 | $124,096 | $367,564 | $355,028 | $358,848 |
| Total Assets | $132,682 | $143,889 | $401,066 | $414,128 | $431,008 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,361 | 39,240 | 37,603 | N/A | N/A |
| Accounts payable and accrued liabilities | 23,296 | 14,144 | 5,810 | 9,317 | 5,390 |
| Accrued Expenses | 19,842 | 11,080 | 16,402 | 11,661 | 13,451 |
| Other current liabilities | 650 | N/A | N/A | N/A | N/A |
| TOTAL | $53,680 | $67,298 | $62,088 | $26,225 | $26,677 |
| Non-Current Liabilities | |||||
| Long Term Debt | 35,927 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 3,531 | 2,834 | 2,273 | 2,196 | 4,828 |
| Other Non-Current Liabilities | 31,505 | 32,436 | 137,849 | 258,519 | 350,356 |
| TOTAL | $70,165 | $35,631 | $140,077 | $288,485 | $385,618 |
| Total Liabilities | $123,845 | $102,929 | $202,165 | $314,710 | $412,295 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,949 | 21,985 | 16,503 | 13,772 | 3,594 |
| Common Shares | 2 | 19 | 15 | 12 | 1 |
| Retained earnings | -899,683 | -841,791 | -645,496 | -663,681 | -563,563 |
| Other shareholders' equity | -5 | 0 | 9 | 0 | 549,857 |
| TOTAL | $8,837 | $40,960 | $198,901 | $99,418 | $18,713 |
| Total Liabilities And Equity | $132,682 | $143,889 | $401,066 | $414,128 | $431,008 |